On July 7, Rhode Island Governor Dan McKee signed legislation that authorizes
a two-year pilot program to prevent drug overdose deaths through the
establishment of harm reduction centers. According to a news release from the
Rhode Island General Assembly, The law quote “aut...
A new Oregon law expands protections and treatment options for Oregonians
living with drug addiction. Senate Bill 755 goes further to enforce Measure
110, which decriminalized drug possession in the state. Tera Hurst works with
the Health Justice Recovery Alliance, a gro...
This week on Century of Lies we examine the protests rocking Colombia.
Congress’s Tom Lantos Human Rights Commission held a hearing on the
Colombia protests July First. We hear from three of the witnesses: Elizabeth
Dickinson, a Senior Analyst for Colombia with the Internat...
This week on Century of Lies, drug policy reform moves forward around the
world. In the US, Representative Cori Bush (D-MO) and Rep. Bonnie Watson
Coleman (D-NJ) introduced the Drug Policy Reform Act on June 15. In Scotland,
the Government has introduced a new drugs policy ...
At a news conference on June 17, 1971, disgraced former president Richard
Nixon announced the start of the modern American drug war. On this edition of
Free Culture Radio, history of the drug war part one, from Nixon through
The International Network of People Who Use Drugs organized a side event at
the recent UN General Assembly High Level Meeting on HIV/AIDS, entitled
“The Right to Rights: How do we get there for People who Use Drugs.” On
this edition of Century of Lies we hear from two of th...
In November, Oregon became the first state to legalize the use of psilocybin,
the main active ingredient in “magic mushrooms,” for mental health
treatment in supervised settings. The field of psychedelic-enhanced therapy
has gained particular momentum as a promising a...
This week: Century does psychedelics. We hear from Professor Peter Hendricks,
PhD with the School of Public Health at the University of Alabama at
Birmingham on special considerations for evaluating psilocybin-facilitated
treatments in vulnerable populations; and from Jazmi...